Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 14, 2012; 18(10): 1067-1076
Published online Mar 14, 2012. doi: 10.3748/wjg.v18.i10.1067
Published online Mar 14, 2012. doi: 10.3748/wjg.v18.i10.1067
Defect | Metabolite | m/z | Median | Range |
3β-hydroxy-Δ5-C27-steroid dehydrogenase deficiency | Glyco-dihydroxy-5-cholenoic acid | 526 | 0.05 | 0.0-0.9 |
HSD3B7 | Glyco-trihydroxy-5-cholenoic acid | 542 | 0.07 | 0.0-0.4 |
16p11.2-12 | Dihydroxy-5-cholenoic acid sulphate | 469 | 0.71 | 0.15-8.1 |
OMIM: 23110 | Trihydroxy-5-cholenoic acid sulphate | 485 | 0.08 | 0.0-2.0 |
Δ4-3-oxosteroid 5-β-reductase deficiency | Glyco-hydroxy-oxo-cholenoic acid | 444 | 0.03 | 0.0-0.4 |
AKR1D1 | Glyco-dihydroxy-oxo-cholenoic acid | 460 | 0.04 | 0.0-2.4 |
7q31 | Tauro-hydroxy-oxo-cholenoic acid | 494 | 0.02 | 0.0-0.5 |
OMIM: 235555 | Tauro-dihydroxy-oxo-cholenoic acid | 510 | 0.04 | 0.0-5.0 |
Defects of peroxisomal biogenesis | Tauro-tri-hydroxycholestanoic acid | 556 | 0.02 | 0.0-0.3 |
Multiple | Tauro-tetra-hydroxycholestanoic acid | 572 | 0.02 | 0.0-0.2 |
OMIM: 214100 | ||||
Sterol 27-hydroxylase deficiency | Glucuronide-5β-cholestane-tetrol | 611 | 0.24 | 0.0-1.6 |
(cerebrotendinous xanthomatosis) | Glucuronide-5β-cholestane-pentol | 627 | 0.37 | 0.1-4.3 |
CYP27A1 | ||||
2q33-qter | ||||
OMIM: 213700 | ||||
Cholestatic liver disease | Glyco-chenodeoxy-cholic acid | 448 | 0.49 | 0.0-5.2 |
Multiple | Glyco-cholic acid | 464 | 0.64 | 0.1-14.6 |
Tauro-chenodeoxy-cholic acid | 498 | 0.05 | 0.0-0.8 | |
Tauro-cholic acid | 514 | 0.08 | 0.0-8.4 |
- Citation: Haas D, Gan-Schreier H, Langhans CD, Rohrer T, Engelmann G, Heverin M, Russell DW, Clayton PT, Hoffmann GF, Okun JG. Differential diagnosis in patients with suspected bile acid synthesis defects. World J Gastroenterol 2012; 18(10): 1067-1076
- URL: https://www.wjgnet.com/1007-9327/full/v18/i10/1067.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i10.1067